Nearly 60% of patients with IgAN in the SPARTAN Study achieved complete remission when using FILSPARI as first-line treatment SPARTACUS…
Additional real-world studies show sustained HAE attack rate reduction after initiating ORLADEYO, regardless of C1-INH status, and patient preference for…
MamaLift ensures personalized care tailored to each woman's journey through motherhood, empowering them to manage stress, embrace joy, and reduce…
NEW YORK, Oct. 18, 2024 /PRNewswire/ -- Legacy, the country's leading sperm testing and freezing company, and Posterity Health, the…
Evvy Names Dr. Kate McLean, MD, MPH, FACOG as Chief Medical Officer, publishes peer-reviewed validation paper for its at-home vaginal…
Temporary marketing authorization is based on statistically significant and clinically meaningful results from the Phase 3 PROTECT TrialSAN DIEGO, Oct.…
MIAMI, FL, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…
SYDNEY, Oct. 15, 2024 /PRNewswire/ -- Cardiex, a global health technology company specializing in cardiovascular diagnostics and devices, today announced…
First-of-its-kind service empowers discreet and more convenient access to testing and treatment for vaginitis and similar genital tract infections such…
Happy Mama Expo 2024 is on Saturday, October 19, 2024, from 7:00 a.m. to 7:00 p.m. Eastern.SAN DIEGO, CA /…